Learn More
Medchemexpress LLC Oritinib | 2035089-28-0 | 99.6% | 539.67 g/mol | C31H37N7O2 | 5 MG

Supplier: Medchemexpress LLC HY1399205MG
Oritinib is an irreversible, third-generation EGFR tyrosine kinase inhibitor developed to overcome T790M-mediated resistance. Supplied as a high-purity solid research compound, it is used in preclinical biochemical and cellular studies to interrogate EGFR signaling and resistance mechanisms.
- Irreversible third-generation EGFR inhibitor.
- Active against T790M resistance mutations.
- High chemical purity (99.6%).
- Provided as a solid suitable for dosing and formulation.
- Applicable to biochemical and cellular assays.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.